Doctor Elias Rawish
Schleswig-Holstein University Clinic, Lubeck Campus, Luebeck (Germany)
Membership:
ESC Professional Member
Biography
Dr. Elias Rawish, MD, is a Clinician Scientist at the University Medical Center Schleswig-Holstein (UKSH), Lübeck. His research bridges clinical cardiology and translational cardiovascular science, focusing on calcific aortic valve stenosis, Takotsubo syndrome, cardiovascular inflammation, and cardiometabolic disease. He leads preclinical and translational projects supported by the German Centre for Cardiovascular Research (DZHK). As Coordinating Investigator of the Horizon Europe-funded SGLT2 HYPE trial, he leads a multinational randomized trial evaluating SGLT2 inhibition in hypertensive patients at cardiovascular risk beyond current indications. His work combines mechanistic research, immunometabolism, translational biomarker studies, and clinical trial leadership to identify novel therapeutic targets and translate biological insights into cardiovascular therapies. He also serves as Young DZHK Co-Speaker for the North site.
Contributor content
Presentation
Semaglutide or tirzepatide in heart failure across ejection fraction phenotypes: a new-user, active-comparator target trial emulation
Presentation
Audiovisual distraction reduces sedative requirements and enhances patient satisfaction during mitral transcatheter edge-to-edge repair
Presentation
Linking brain innate immunity, energy metabolism, and HFpEF: hypothalamic complement C3/C3a/C3aR pathway drives cardiometabolic syndrome and HFpEF via central SOCS3 activation
Presentation
